Showing 3 Result(s)

How IRICoR Plays a Key Role in Translational Research

In the relentless battle against cancer, Montreal-based IRICoR dedicates itself to catalyzing the translation of groundbreaking research into tangible therapies that benefit patients. As a Centre of Excellence for Commercialization and Research, IRICoR’s mission is to identify promising cancer research emanating from Canadian universities, facilitate its development into viable treatments, and ultimately, expedite their delivery to patients in need.

Steven Klein, Vice President of Business Development at IRICoR, explains the intricate journey that research must undertake from the laboratory to the clinic.


Sanofi Canada’s Commitment to Diabetes Care

Diabetes stands as a formidable challenge in the realm of chronic diseases, impacting millions globally and presenting a significant concern in Canada. With approximately 10 percent of Canadians currently affected, projections suggest a rise to 12 percent by 2030.

Beyond the physical toll, diabetes deeply influences individuals’ quality of life, touching upon emotional and mental well-being while demanding significant lifestyle adjustments and ongoing monitoring.

Addressing Mental Health in Diabetes Care

Recognizing the multifaceted impact of diabetes, Sanofi Canada has …

How Technology is Shaping the New Normal in Canada

As Canadians strive to move past the challenges posed by the COVID-19 pandemic, there’s a palpable desire to return to a semblance of normalcy. However, this crisis has prompted us to rethink our approach to healthcare, pushing us to embrace innovative technologies and new ways of delivering care.

The result? A new “normal” that promises to be markedly different from the old.

Prior to the pandemic, concepts like virtual house calls, remote diagnostics, and self-testing were largely unfamiliar and even frowned upon by some. But necessity breeds innovation, and as the need for socially distant …